IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q3 2016 Holdings

Filed 2016-11-14 | 18 holdings | $57.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$16.7K2,563,92529.3%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$8.0K1,359,76714.1%
Synthetic Biologics Inc.COM87164U102$6.6K3,734,14911.6%
Vascular Biogenics LTDCOMM96883109$4.4K860,6057.7%
Cempra IncCOM15130J109$4.3K180,8007.6%
Advaxis Inc.COM NEW7624208$2.9K275,0005.0%
Alcobra LtdSHSM2239P109$2.8K1,115,3154.9%
Volition RX LTD(VNRX)COM928661107$2.6K461,5384.5%
Ampio Pharmaceuticals Inc.COM03209T109$2.1K2,738,3223.6%
Newlink Genetics CorpCOM651511107$1.5K102,4372.6%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.0K135,8001.8%
Keryx Biopharmaceuticals Inc.COM492515101$1.0K200,0001.8%
Ritter Pharmaceuticals, IncCOM767836109$869526,9031.5%
Advaxis Inc.W EXP 07/15/2017624117$750112,5001.3%
OHR Pharmaceutical IncCOM NEW67778H200$568205,0001.0%
Bio Blast Pharma LtdSHSM20156101$424250,9700.7%
Caladrius Biosciences IncCOM128058104$26655,7810.5%
Champions Oncology Inc(CSBR)COMM NEW15870P307$184111,1110.3%